Gender differences in long-term survival post-transplant: A single-institution analysis in the lung allocation score era

Clin Transplant. 2017 Mar;31(3):10.1111/ctr.12889. doi: 10.1111/ctr.12889. Epub 2017 Feb 8.

Abstract

The purpose of this study was to clarify the significance of recipient gender status on lung transplant outcomes in a large single-institution experience spanning three decades, we analyzed data from all lung transplants performed in our institution since 1986. Kaplan-Meier curves and Cox proportional hazard models were used to evaluate the effect of recipient characteristics on survival and BOS score ≥1-free survival. Logistic regression analysis was used to explore the association of gender with short-term graft function. About 876 lung transplants were performed between 1986 and 2016. Kaplan-Meier survival estimates at 5 years post-transplant for females vs males in the LAS era were 71% vs 58%. In the LAS era, females showed greater unadjusted BOS≥1-free survival than males (35% vs 25%, P=.02) over 5 years. Female gender was the only factor in the LAS era significantly associated with improved adjusted 5-year survival [HR 0.56 (95% CI 0.33, 0.95) P=.03]. Conversely, in the pre-LAS era female gender was not associated with improved survival. Female recipients showed significantly improved survival over 5 years compared to males in the LAS era. A prospective analysis of biologic and immunologic differences is warranted.

Keywords: bronchiolitis obliterans syndrome; clinical outcomes; gender; lung transplant; primary graft dysfunction; recipient factors.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Rejection / mortality*
  • Graft Survival
  • Humans
  • Lung Diseases / mortality*
  • Lung Diseases / surgery
  • Lung Transplantation / mortality*
  • Male
  • Middle Aged
  • Postoperative Complications / mortality*
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Survival Rate
  • Tissue and Organ Procurement*